相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meta-analysis reveals an association between signal transducer and activator of transcription-4 polymorphism and hepatocellular carcinoma risk
Li Zhang et al.
HEPATOLOGY RESEARCH (2017)
Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma
Jing-Tao Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma
Wenjie Zheng et al.
TUMOR BIOLOGY (2016)
Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population
Aihua Tan et al.
TUMOR BIOLOGY (2016)
Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics
Kyung-A Hyun et al.
ANALYST (2016)
Serum protein biomarkers relevant to hepatocellular carcinoma and their detection
Eric Waidely et al.
ANALYST (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases
Li Li et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Screening for hepatocellular carcinoma in high-risk populations
Zoe A. Miller et al.
CLINICAL IMAGING (2016)
Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women
Yang Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
HBV: Do I treat my immunotolerant patients?
Jiannis Vlachogiannakos et al.
LIVER INTERNATIONAL (2016)
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
Caecilia H. C. Sukowati et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma
Mingjie Yao et al.
ONCOTARGET (2016)
Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations
Song Yao et al.
ONCOTARGET (2016)
Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B
Ju Dong Yang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls
Robin K. Kelley et al.
BMC CANCER (2015)
Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis
Jun-Li Fan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Circulating tumor cells are correlated with disease progression and treatment response in an orthotopic hepatocellular carcinoma model
Jun Yan et al.
CYTOMETRY PART A (2015)
Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population
Rentao Yu et al.
HEPATITIS MONTHLY (2015)
Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells
Thomas Vanwolleghem et al.
HEPATOLOGY (2015)
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)
Norihiro Kokudo et al.
HEPATOLOGY RESEARCH (2015)
Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma
Patrick Reichl et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
Nicolas Pote et al.
JOURNAL OF HEPATOLOGY (2015)
Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands
Suzanne van Meer et al.
JOURNAL OF HEPATOLOGY (2015)
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
Zhengju Xu et al.
MEDICINE (2015)
Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population
Jia-Yan Yao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
Seung Up Kim et al.
YONSEI MEDICAL JOURNAL (2015)
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration
Lindsay Y. King et al.
GUT (2015)
Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma
Andre Nogueira da Costa et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Reappraisal of serum alpha-foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment
Gi-Ae Kim et al.
LIVER INTERNATIONAL (2015)
Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis
Meiyu Dai et al.
PLOS ONE (2015)
Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies
Kailiu Wu et al.
TUMOR BIOLOGY (2015)
Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis
Jian Zhang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma
Gary L. Norman et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients
Tilman D. Rachner et al.
BMC CANCER (2014)
Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma
Choong-Kyun Noh et al.
CLINICAL BIOCHEMISTRY (2014)
Serum interleukin-6 associated with hepatocellular carcinoma risk: A nested case-control study
Waka Ohishi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Antitumor function of microRNA-122 against hepatocellular carcinoma
Kazuhiko Nakao et al.
JOURNAL OF GASTROENTEROLOGY (2014)
'Liver let die': oxidative DNA damage and hepatotropic viruses
Martin R. Higgs et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma
Qi-Kai Sun et al.
MEDICAL ONCOLOGY (2014)
Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma
Hsiang-Yun Cheng et al.
PLOS ONE (2014)
被撤回的出版物: Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels (Retracted article. See April, 2017)
Wan-Ju Xu et al.
TUMOR BIOLOGY (2014)
Diagnostic Performance of Des-gamma-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
Rong Zhu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2014)
Primary yolk sac tumor of the retroperitoneum: A case report and review of the literature
Yang-Long Guo et al.
ONCOLOGY LETTERS (2014)
Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysis
Hao-Guang Wan et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis
Jie Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
A Combination of α-Fetoprotein and Des-γ-Carboxy Prothrombin Is Superior in Detection of Hepatocellular Carcinoma
Judith M. Ertle et al.
DIGESTION (2013)
Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
Tai-Chung Tseng et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
Caroline D. M. Witjes et al.
HEPATOLOGY INTERNATIONAL (2013)
Evaluation of Individual and Combined Applications of Serum Biomarkers for Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
Bin Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B
Keiko Arataki et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
From -omics to personalized medicine in nephrology: integration is the key
Francesco Pesce et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Yu-Ju Lin et al.
PLOS ONE (2013)
Ischemic Postconditioning-Mediated miRNA-21 Protects against Cardiac ischemia/reperfusion Injury via PTEN/Akt Pathway
Yingfeng Tu et al.
PLOS ONE (2013)
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP
Jong Young Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
Hui Xie et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol
Ting-Shuo Huang et al.
SYSTEMATIC REVIEWS (2013)
Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma
Abeer M. Nafee et al.
CLINICAL BIOCHEMISTRY (2012)
Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma
Jeong Won Jang et al.
CYTOKINE (2012)
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach
Bingbing Qiao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
Qiujin Shen et al.
LANCET ONCOLOGY (2012)
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL
Hidenori Toyoda et al.
CANCER SCIENCE (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review
Fei Jin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dickkopfs and Wnt/β-catenin signalling in liver cancer
Sarwat Fatima et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2011)
Assessment of Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma in Middle Eastern Patients
Faisal M. Sanai et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2010)
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
Kentaroh Yamamoto et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis
Yi Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma
Changzheng Liu et al.
JOURNAL OF HEPATOLOGY (2010)
Application of OMICS technologies in occupational and environmental health research; current status and projections
J. Vlaanderen et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2010)
Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma
M. C. Kew
PATHOLOGIE BIOLOGIE (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis
Myron John Tong et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Dickkopf-1: a suitable target for the management of myeloma bone disease
Maria Gavriatopoulou et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Hepatitis B: Liver fibrosis and hepatocellular carcinoma
A. S. F. Lok
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Hepatitis B and Hepatocellular Carcinoma
Adrian M. Di Bisceglie
HEPATOLOGY (2009)
High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
Vincent Wai-Sun Wong et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome
Richard Todd Stravitz et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
Masatoshi Makuuchi et al.
HEPATOLOGY RESEARCH (2008)
Toward the proteomic identification of boomarkers for the prediction of HBV related hepatocellular carcinoma
Qing-Yu He et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma
Henry Lik-Yuen Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Drug therapy - Hepatitis B virus infection
Jules L. Dienstag
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
miR-21-mediated tumor growth
M.-L. Si et al.
ONCOGENE (2007)
The utility of Lens culinaris agglutinin-reactive α-fetoprotein in the diagnosis of hepatocellular carcinoma:: Evaluation in a United States referral population
Apinya Leerapun et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Glypican-3: From the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma
Baruch D. Jakubovic et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
JA Marrero et al.
JOURNAL OF HEPATOLOGY (2005)
Heat-shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis
JT Feng et al.
PROTEOMICS (2005)
Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling
MI Capurro et al.
CANCER RESEARCH (2005)
The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma
RB Guerrero et al.
JOURNAL OF HEPATOLOGY (2005)
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma
P Pontisso et al.
BRITISH JOURNAL OF CANCER (2004)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model
MG Peters et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
RF Velázquez et al.
HEPATOLOGY (2003)
Alpha-fetoprotein, the major fetal-serum protein, is not essential for embryonic development but is required for female fertility
P Gabant et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease
RD Kladney et al.
HEPATOLOGY (2002)
Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
BJ McMahon et al.
HEPATOLOGY (2000)
Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53
J Wang et al.
ONCOGENE (2000)
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
MF Yuen et al.
HEPATOLOGY (2000)
分享论文
